Silexion Therapeutics Corp. (NASDAQ: SLXN) announced it has received approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE